Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
MEL-
Unknown
Show more
Pharmaceutical preparations for the treatment of the musculoskeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's cerebral palsy, Parkinson's disease; for the treatment of cardiovascular diseases; for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; for the treatment of erosion and ulceration of the esophagus; for the treatment of gastro-intestinal diseases; for the treatment of insomnia; for the treatment of cancer and for the treatment of blood disorders and calcium channel blockers, antidepressants and anticonvulsants.
Class 5 – Pharmaceuticals & supplements
Status timeline
- 4 Mar 2010Application filed
- 28 Jul 2010Published
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of the musculoskeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's cerebral palsy, Parkinson's disease; for the treatment of cardiovascular diseases; for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; for the treatment of erosion and ulceration of the esophagus; for the treatment of gastro-intestinal diseases; for the treatment of insomnia; for the treatment of cancer and for the treatment of blood disorders and calcium channel blockers, antidepressants and anticonvulsants.
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official Canada trademark register. This record was last updated on 24 Sep 2014; the index was built on 20 Nov 2026 and covers data through 28 Jan 2025. View official record → If the two differ, the official record is correct.